Posted by Michael Wonder on 03 Feb 2021
Cost recovery implementation statement (2020-2021)
3 February 2021 - This Cost Recovery Implementation Statement provides information on how the Therapeutic Goods Administration, within the Department of Health, implements and cost recovers its regulatory activities.
The feedback from the submissions was put forward to Government for consideration along with the proposed fees and charges for 2020-21.
Feedback was taken into account and with a view to minimise impact on industry only indexation increase of 1.95% in fees and charges was approved despite more than 4% increase in expenses in 2020-21.
